Sign in

CIK 0001367644 · Accelerated filer

Emergent BioSolutions Inc.

Sign in to watch
Ticker
EBS
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
141902018
Phone
240-631-3200
Business address
300 PROFESSIONAL DR, GAITHERSBURG, MD, 20879
  1. 144 Insider Sale of Securities
  2. 144 Insider Sale of Securities
  3. 10-Q Report Quarterly Report
  4. S-8 Other Securities Offered to Employees in Benefit Plans
  5. 8-K Event Results of operations · Regulation FD disclosure
  6. 144 Insider Sale of Securities
  7. 8-K Event Shareholder vote results
  8. SCHEDULE 13G Stake Statement of Beneficial Ownership
  9. DEFA14A Proxy Proxy Materials
  10. DEFA14A Proxy Proxy Materials
  11. DEFA14A Proxy Proxy Materials
  12. 8-K Event Material agreement · Agreement ended · Unregistered share sale · Regulation FD disclosure
  13. DEFA14A Proxy Proxy Materials
  14. DEFA14A Proxy Proxy Materials
  15. SCHEDULE 13G Stake Statement of Beneficial Ownership
  16. 4 Planned sale SVP, Products Business sold 4,000 shares at $8.44 ($33,760)
  17. 144 Insider Sale of Securities
  18. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  19. ARS Other Annual Report to Security Holders
  20. DEFA14A Proxy Proxy Materials

Page 3 of 87 · 1,733 filings